Sodium Hydroxide
CAS 1310-73-2
Sodium Hydroxide (CAS 1310-73-2) is a pharmaceutical compound with 0 bioactivity targets and 8 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| SODIUM HYDROXIDE | 9880 | SU | MTHSPL |
| Sodium Hydroxide | 9880 | SU | MTHSPL |
| Sodium hydroxide | 9880 | SU | MTHSPL |
| sodium hydroxide | 9880 | SU | MTHSPL |
| sodium hydroxide | 9880 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Sodium Hydroxide used for in pharmaceutical contexts?
Sodium Hydroxide (CAS 1310-73-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Sodium Hydroxide?
Sodium Hydroxide has 8 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Completed suicide, Suspected suicide, Toxicity to various agents. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Sodium Hydroxide also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Sodium Hydroxide with EU status "restricted".
What clinical phase is Sodium Hydroxide in?
No phase 1-4 clinical development badge is rendered for Sodium Hydroxide because the matched compound identifier rows do not contain a max-phase value.